Abstract
CRISPR–Cas13 systems have been developed for precise RNA editing, and can potentially be used therapeutically when temporary changes are desirable or when DNA editing is challenging. We have identified and characterized an ultrasmall family of Cas13b proteins—Cas13bt—that can mediate mammalian transcript knockdown. We have engineered compact variants of REPAIR and RESCUE RNA editors by functionalizing Cas13bt with adenosine and cytosine deaminase domains, and demonstrated packaging of the editors within a single adeno-associated virus.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Deep sequencing data from whole-transcriptome sequencing were deposited as a BioProject under Project ID PRJNA641934. Data from the main figures are available in the Supplementary Information.
Code availability
All Python scripts used for data analysis are available in a GitHub repository found at https://github.com/fengzhanglab/Cas13bt-analysis.
References
Terns, M. P. CRISPR-based technologies: impact of RNA-targeting systems. Mol. Cell 72, 404–412 (2018).
Cox, D. B. T. et al. RNA editing with CRISPR-Cas13. Science 1027, 1019–1027 (2017).
Abudayyeh, O. O. et al. A cytosine deaminase for programmable single-base RNA editing. Science 365, 382–386 (2019).
Dong, J. Y., Fan, P. D. & Frizzel, R. A. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7, 2101–2112 (1996).
Wu, Z., Yang, H. & Colosi, P. Effect of genome size on AAV vector packaging. Mol. Ther. 18, 80–86 (2010).
Smargon, A. A. et al. Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28. Mol. Cell 65, 618–630 (2017).
Abudayyeh, O. O. et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353, aaf5573 (2016).
Gootenberg, J. S. et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a and Csm6. Science 360, 439–444 (2018).
Matthews, M. M. et al. Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity. Nat. Struct. Mol. Biol. 23, 426–433 (2016).
MacDonald, B. T., Tamai, K. & He, X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9–26 (2009).
Apte, U. et al. Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury. Am. J. Pathol. 175, 1056–1065 (2009).
Bhushan, B. et al. Pro-regenerative signaling after acetaminophen-induced acute liver injury in mice identified using a novel incremental dose model. Am. J. Pathol. 184, 3013–3025 (2014).
Kattenhorn, L. M. et al. Adeno-associated virus gene therapy for liver disease. Hum. Gene Ther. 27, 947–961 (2016).
Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172–1179 (2017).
Crooks, G. E., Hon, G., Chandonia, J. M. & Brenner, S. E. WebLogo: a sequence logo generator. Genome Res. 14, 1188–1190 (2004).
Keegan, K. P., Glass, E. M. & Meyer, F. MG-RAST, a metagenomics service for analysis of microbial community structure and function. Methods Mol. Biol. 1399, 207–233 (2016).
Nordberg, H. et al. The genome portal of the Department of Energy Joint Genome Institute: 2014 updates. Nucleic Acids Res. 42, 26–31 (2014).
Chen, I. M. A. et al. The IMG/M data management and analysis system v.6.0: new tools and advanced capabilities. Nucleic Acids Res. 49, D751–D763 (2020).
Shmakov, S. A., Makarova, K. S., Wolf, Y. I., Severinov, K. V. & Koonin, E. V. Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis. Proc. Natl Acad. Sci. USA 115, E5307–E5316 (2018).
Eddy, S. R. Accelerated profile HMM searches. PLoS Comput. Biol. 7, e1002195 (2011).
Steinegger, M. & Söding, J. MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nat. Biotechnol. 35, 1026–1028 (2017).
Steinegger, M. & Söding, J. Clustering huge protein sequence sets in linear time. Nat. Commun. 9, 2542 (2018).
Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772–780 (2013).
Steinegger, M. et al. HH-suite3 for fast remote homology detection and deep protein annotation. BMC Bioinformatics 20, 1–15 (2019).
Makarova, K. S. et al. Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants. Nat. Rev. Microbiol. 18, 67–83 (2019).
Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2 - approximately maximum-likelihood trees for large alignments. PLoS ONE 5, e9490 (2010).
Joung, J. et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat. Protoc. 12, 828–863 (2017).
Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759–771 (2015).
Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101–1108 (2008).
Hrvatin, S., Deng, F., O’Donnell, C. W., Gifford, D. K. & Melton, D. A. MARIS: method for analyzing RNA following intracellular sorting. PLoS ONE 9, e89459 (2014).
Veeman, M. T., Slusarski, D. C., Kaykas, A., Louie, S. H. & Moon, R. T. Zebrafish Prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr. Biol. 13, 680–685 (2003).
Glusman, G., Caballero, J., Mauldin, D. E., Hood, L. & Roach, J. C. Kaviar: an accessible system for testing SNV novelty. Bioinformatics 27, 3216–3217 (2011).
Shen, S., Troupes, A. N., Pulicherla, N. & Asokan, A. Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated Virus 4. J. Virol. 87, 13206–13213 (2013).
Grieger, J. C., Choi, V. W. & Samulski, R. J. Production and characterization of adeno-associated viral vectors. Nat. Protoc. 1, 1412–1428 (2006).
Acknowledgements
We thank E. Eloe-Fadrosh for generously sharing JGI data from study Ga0114919; D. L. Valentine and J. Tarn for generously sharing JGI data from study Ga0180434; E. Puccio for assistance with AAV production; F. E. Demircioglu for assistance with protein purification; members of the laboratory of F.Z. for advice and discussions, R. Macrae for discussion and editing of the manuscript, and R. Belliveau for technical support. S.K. is supported by a National Science Foundation Graduate Research Fellowship. F.Z. is supported by NIH grants (1R01-HG009761, 1R01-MH110049 and 1DP1-HL141201), HHMI, Open Philanthropy, The G. Harold and Leila Y. Mathers Charitable, Bill and Melinda Gates, and Edward Mallinckrodt, Jr Foundations, the Poitras Center for Psychiatric Disorders Research at MIT, the Hock E. Tan and K. Lisa Yang Center for Autism Research at MIT, the Yang-Tan Center for Molecular Therapeutics, and by L. Yang, the Phillips family and J. and P. Poitras.
Author information
Authors and Affiliations
Contributions
S.K., H.A.-T. and F.Z. conceived the project and designed the computational pipeline and experiments. H.A.-T. performed computational searching and phylogenetic analysis with input from K.S.M. and E.V.K. S.K. and H.A.-T. performed the essential gene screen experiment and H.A.-T. analyzed the results. X.J. performed the transcriptome-wide specificity sequencing experiment, and S.K. analyzed the results. V.M. produced AAV and assisted with design of AAV constructs and experiments. S.K. performed and analyzed results from all other experiments with assistance from X.J., R.O. and V.M. S.K., H.A.-T. and F.Z. drafted the manuscript with input from all authors.
Corresponding author
Ethics declarations
Competing interests
F.Z. is a co-founder of Editas Medicine, Beam Therapeutics, Pairwise Plants, Arbor Biotechnologies and Sherlock Biosciences. S.K., H.A.-T. and F.Z. are co-inventors on US provisional patent application 62/905,645 relating to the Cas proteins described in this manuscript. The remaining authors declare no competing interests.
Additional information
Peer review information Nature Biotechnology thanks Magdy Mahfouz, Mitchell O’Connell and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Methods, Figs. 1–10, Tables 1–11, Note 1 and References.
Supplementary Tables
Supplementary Tables 4–6, 8 and 11.
Supplementary Data
Unprocessed gel for Supplementary Fig. 4a.
Rights and permissions
About this article
Cite this article
Kannan, S., Altae-Tran, H., Jin, X. et al. Compact RNA editors with small Cas13 proteins. Nat Biotechnol 40, 194–197 (2022). https://doi.org/10.1038/s41587-021-01030-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-021-01030-2
This article is cited by
-
TaqTth-hpRNA: a novel compact RNA-targeting tool for specific silencing of pathogenic mRNA
Genome Biology (2024)
-
Programmed RNA editing with an evolved bacterial adenosine deaminase
Nature Chemical Biology (2024)
-
Structures, mechanisms and applications of RNA-centric CRISPR–Cas13
Nature Chemical Biology (2024)
-
dCas13-mediated translational repression for accurate gene silencing in mammalian cells
Nature Communications (2024)
-
CRISPR technologies for genome, epigenome and transcriptome editing
Nature Reviews Molecular Cell Biology (2024)